The outbreak of Severe Acute Respiratory Syndromes Coronavirus-2 (SARS-CoV-2) is a global catastrophe. The elderly and people with co-morbidity are facing a serious complication of the disease. The entry and infection strategy of SARS-CoV-2 in a host cell is raised by an amazing way of ACE2 receptor recognition and imbalance of ACE/ACE2 in various organs, especially in the lungs. Here it has been discussed that during the receptor-recognition (beginning of infection), interferon, protease and followed by cytokine induction, hypoxia plays a significant role in the context of the balance of ACE/ACE2. It has also been very concisely delineated the biochemistry and mechanism of ACE/ACE2 balance in different stages of infection and its role in comorbidity.

Keywords:
SARS-CoV-2, ACE/ACE2, Comorbidity, Hypoxia
Subjects:
Cardiovascular System & Vascular Biology, Molecular Bases of Health & Disease, Virology
This content is only available as a PDF.
Copyright 2021 The Author(s)
2021
This is an Accepted Manuscript; not the final Version of Record. You are encouraged to use the final Version of Record that, when published, will replace this manuscript and be freely available under a Creative Commons licence.